Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen (PAPRIKA)
This study is ongoing, but not recruiting participants.
Study NCT00417209
Information provided by Sanofi-Aventis
First Received: December 28, 2006
Last Updated: July 7, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
